utahgal7 wrote:1)Along with elevated ALP levels, some patients with bone mets may have (not always) hypercalcemia (elevated blood calcium). Has your blood calcium been elevated recently?
We used menatetrenone (the vitamin K2 isoform also known as MK4) to knock down hypercalcemia, and based on her lab tissue tests and blood data, to amplify 5FU - LV cell kill. Some earlier lab data in a paper had shown some 2 out of 4 lab lines of CRC cells inhibited by MK4 alone.
...
3) What is your pain level and sleeping pattern? When my father had bone mets, the pain was excruciating and unrelenting. The pain was worse at night and it was so bad, he was unable to sleep most nights. My dad was prescribed very strong opioids and had to go to the ER numerous times for pain management.
This sounds like one of the fight harder/smarter opportunities missed by "standard" protocols.
"worse at night" - decades of chronomodulation data says that ~3am is
the time for a peak dose of 5FU.
So the xeloda chronomodulation papers have big doses at 12 midnight and about 7am - this is part of the last + in ADAPT++++ improvements, far beyond ADAPT. My wife's UFT chronomodulation was more primitive, with the biggest (5FU) dose first thing in the morning with more instant 5FU release from UFT. Standard xeloda protocols say, "duh, gee, what's up doc?"
My dad was prescribed very strong opioids and had to go to the ER numerous times for pain management.
Some CRC cancer cell lines are inhibited by high IVC levels and/or celecoxib. Since opioids stimulate cancer growth, we maximized IVC and NSAIDS (tramadol for surgery instead of morphine, then celecoxib afterwards)
with 5FU. IVC relieves acute pain for some hours, and to a lesser degree, perhaps several days. Carrying 2+ cm LNs, long before we had her optimized chemo load, my wife was doing IVC 4x-5x a week, where she had relief or at least, a self driven strong urge. Once she was better after surgery #2 removed the LN, it was hard to keep her doing IVC 1.5x - 2x a week. Over the next 2 years we tested and improved her oral chemo formula more, for her personal biology, but still behind ADAPT++++ now in several aspects.
Situations like utahgal describes is what we worked hard to avoid, and figure out, if necessary, the pedal-to-the-metal off label versions to attack mets with oral formulations that have mild side effects.